Boston Scientific, a medical device company, has lowered its revenue outlook for 2026 due to challenges in key revenue drivers. Initially, the company expected net sales growth of 10% to 11% on an organic basis. However, this range was reduced to 6.5% and 8% a few months ago and has now been further reduced to 5% to 6%.
Impact on the Company
The reduction in revenue outlook may lead to layoffs as the company adjusts to the new expectations. Boston Scientific is based in Marlborough, Massachusetts, and the changes may affect its operations and employees in the area.
Original reporting: NBC10 Boston — read the source article.
